INVESTOR ALERT: Edelson Lechtzin LLP is advising Altimmune, Inc. (NASDAQ: ALT) shareholders who have experienced significant losses to seek legal advice regarding the ongoing securities fraud class action.

May 16, 2024

XLV Health Care
ALT, Altimmune, Inc.

NEWTOWN, Pa., May 16, 2024 (GLOBE NEWSWIRE) — Edelson Lechtzin LLP, a leading class action law firm, is investigating alleged violations of the federal securities laws by certain officers and…

Read More: https://www.globenewswire.com/news-release/2024/05/16/2883814/0/en/INVESTOR-ALERT-Edelson-Lechtzin-LLP-Urges-Altimmune-Inc-NASDAQ-ALT-Shareholders-With-Substantial-Losses-To-Consult-Counsel-About-The-Pending-Securities-Fraud-Class-Action.html

Sector Investors News and Insights

INVESTOR ALERT: Edelson Lechtzin LLP is advising Altimmune, Inc. (NASDAQ: ALT) shareholders who have experienced significant losses to seek legal advice regarding the ongoing securities fraud class action.

© 2025 ETF Sector

Sector Investors News and Insights

INVESTOR ALERT: Edelson Lechtzin LLP is advising Altimmune, Inc. (NASDAQ: ALT) shareholders who have experienced significant losses to seek legal advice regarding the ongoing securities fraud class action.

© 2025 ETF Sector

Subscribe to our Newsletter